Chimovits Erezinsider trades
In SEC Form 4 filings, Chimovits Erez is listed as Director of ADARx Pharmaceuticals, Inc. (ADRX). In the last 90 days, Chimovits Erez bought $1.05M of ADARx Pharmaceuticals, Inc. (ADRX) on the open market and sold none. The purchase was $1.05M of ADARx Pharmaceuticals, Inc. (ADRX) on Sep 28. Took part in a cluster buy; the latest at ADARx Pharmaceuticals, Inc. (ADRX), where 5 insiders bought within 1 day, ending Sep 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | Director | 9 | Sep 30 |
Cluster buys
- ADRX: 5 insiders bought $87.75M between Sep 28.
Form 4 historysince 2026-09-30
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 7,127,019 | not reported | not reported | 7,127,019 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 1,333,975 | not reported | not reported | 8,460,994 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 513,067 | not reported | not reported | 8,974,061 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C | 256,448 | not reported | not reported | 9,230,509 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 7,127,019 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 1,333,975 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 513,067 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 30 | C · derivative | 256,448 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.